Fresenius (ETR:FRE) price target bumped up to 78.00EUR, reported earlier today by BNP PARIBAS
- Updated: September 17, 2016
Only yesterday Fresenius (ETR:FRE) traded 0.00% even at 69.28EUR. The company’s 50-day average is 0.00EUR and its 200-day moving average is 0.00EUR. With the last stock price up 0.00% from the 200-day moving average, compared with the S&P 500 Index which has fallen -0.01% over the date range. Trading volume was held steady, with 0 shares of FRE changing hands on par with the typical 0 shares..
BNP PARIBAS upped the target stock price of Fresenius (ETR:FRE) to 78EUR, reporting a possible upside of 0.13%,
Fresenius has a 52 week low of 0.00EUR and a 52 week high of 0.00EUR . FRE’s market cap is currently 0.0 EUR.
General Company Details For Fresenius (ETR:FRE)
Fresenius SE & Co KGaA is a health care company. It operates in the healthcare sector and offers products and services for dialysis, hospitals and outpatient medical care. It focuses on the hospital operations and offers engineering and services for hospitals and other health care facilities. The Company’s operating segments include Fresenius Medical Care; Fresenius Kabi; Fresenius Helios and Fresenius Vamed. The Fresenius Medical Care segment provides dialysis care and dialysis products for patients with chronic kidney failure. The Fresenius Kabi segment is engaged in provision of intravenously administered drugs (IV drugs), infusion therapies, and clinical nutrition and outpatient care. The Fresenius Helios segment is a private hospital operator and operates 72 clinics. The Fresenius Vamed segment provides engineering and services for hospitals and other health care facilities internationally.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.